Patient Guide: Placebo-controlled, Study of Concurrent Chemoradiation Therapy With Pembrolizumab Followed by Pembrolizumab and Olaparib in Newly Diagnosed Treatment-Naïve Limited-Stage Small Cell Lung Cancer (LS-SCLC) (MK 7339-013/KEYLYNK-013)

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 187 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT04624204
Status: ACTIVE_NOT_RECRUITING
Condition: Lung Neoplasms, Small Cell Lung Carcinoma
Phase: PHASE3

Find a Study Location Near You

This study is available at 187 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Chandler, Arizona
  • Loma Linda, California
  • Washington, District of Columbia
  • • And 184 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily